CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
37,68Â US$
arrow_upward
+1,37%(+0,51) 1K
9-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoCHGCF tikeri uchun statistika yaratilmoqda...
Ochish
35,51Â US$
Yuqori
39,29Â US$
Past
35,51Â US$
Bozor kapitali
10,11Â trln
Oʻrtacha hajm
11,21Â ming
Hajmi
9,02Â ming
52 haftalik eng yuqori
68,08Â US$
52 haftalik eng past
34,79Â US$
Beta
1,91
Muomaladagi aksiyalar
1,68Â mlrd
Xodimlar soni
5Â ming
Ochish
35,51Â US$
Yuqori
39,29Â US$
Past
35,51Â US$
Bozor kapitali
10,11Â trln
Oʻrtacha hajm
11,21Â ming
Hajmi
9,02Â ming
52 haftalik eng yuqori
68,08Â US$
52 haftalik eng past
34,79Â US$
Beta
1,91
Muomaladagi aksiyalar
1,68Â mlrd
Xodimlar soni
5Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
18 soat oldin
Citi keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00
Profil
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Chugai Pharmaceutical Co Ltd haqida
CEOOsamu Okuda
Xodimlar soni5,1Â ming
Asos solingan10-mar, 1925
Bosh ofislar-
Sektor-
Veb-saytchugai-pharm.co.jp